aimovig - erenumab - aooe injection
(Erenumab-Aooe)Amgen Inc
Usage: Aimovig is used to prevent migraines in adults.
Amgen Inc drugs
10 results
aranesp - darbepoetin alfa injection, solution
(Darbepoetin Alfa)Amgen Incbkemv - eculizumab - aeeb injection, solution, concentrate
(Eculizumab-Aeeb)Amgen IncUsage: BKEMV is a complement inhibitor indicated for paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis, atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy, and generalized myasthenia gravis (gMG) in AChR antibody-positive adults. Not indicated for STEC-HUS.corlanor - ivabradine tablet, film coated
(Ivabradine)Amgen Incepogen - epoetin alfa solution
(Epoetin Alfa)Amgen Incimlygic - talimogene laherparepvec injection, suspension
(Talimogene Laherparepvec)Amgen IncUsage: IMLYGIC is an oncolytic viral therapy for local treatment of unresectable cutaneous, subcutaneous, and nodal lesions in melanoma patients who have had a recurrence after initial surgery. It has not been shown to improve overall survival or affect visceral metastases.lumakras - sotorasib tablet, coated
(Sotorasib)Amgen IncUsage: Lumakras treats adults with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (after at least one prior therapy) and KRAS G12C-mutated metastatic colorectal cancer (combined with panitumumab, after prior fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy).mvasi - bevacizumab - awwb injection, solution
(Bevacizumab-Awwb)Amgen Incsensipar - cinacalcet hydrochloride tablet, coated
(Cinacalcet Hydrochloride)Amgen IncUsage: Sensipar treats secondary hyperparathyroidism in adult chronic kidney disease patients on dialysis, and hypercalcemia in adults with parathyroid carcinoma or primary hyperparathyroidism unable to undergo parathyroidectomy. Not indicated for CKD patients not on dialysis.tezspire - tezepelumab - ekko injection, solution
(Tezepelumab-Ekko)Amgen IncUsage: Tezspire is indicated as add-on maintenance treatment for adults and patients aged 12 and older with severe asthma, and for inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP). Not for relief of acute bronchospasm or status asthmaticus.